Alpha-9 Theranostics
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
1
Funding Rounds
$127.8m
Money raised
Overview
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Pe**** |
|
- |
Funding series
Funding Series Analysis
The company Alpha-9 Theranostics has raised a total of $127.75m in funding over 1 rounds.
Key Insights:
- Alpha9 Theranostics October 2024 Series C Funding Round: $127.75m
Alpha9 Theranostics October 2024 Series C Funding Round
$127.75m
Industries
Alpha-9 Theranostics is active in the following industries:
- Biotechnology
- Life science
- Genetics
- Pharmaceutical industry